Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.

Epperla N, Pham AQ, Burnette BL, Wiseman GA, Habermann TM, Macon WR, Ansell SM, Inwards DJ, Micallef IN, Johnston PB, Markovic SN, Porrata LF, Colgan JP, Ristow KM, Nowakowski GS, Witzig TE.

Br J Haematol. 2017 Aug;178(3):427-433. doi: 10.1111/bjh.14688. Epub 2017 May 3.


Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.

Du L, Yamamoto S, Burnette BL, Huang D, Gao K, Jamshidi N, Kuo MD.

Cancer Med. 2016 Aug;5(8):1962-72. doi: 10.1002/cam4.719. Epub 2016 Jun 18.


Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.

Yamamoto S, Huang D, Du L, Korn RL, Jamshidi N, Burnette BL, Kuo MD.

Radiology. 2016 Jul;280(1):261-70. doi: 10.1148/radiol.2016160259. Epub 2016 Apr 15.


Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management.

Burnette BL, Jentoft MA, Porrata LF, Boyce TG, Witzig TE.

J Clin Oncol. 2014 Mar 1;32(7):e14-7. doi: 10.1200/JCO.2012.47.6994. Epub 2014 Jan 6. No abstract available.


Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.

Burnette BL, Dispenzieri A, Kumar S, Harris AM, Sloan JA, Tilburt JC, Kyle RA, Rajkumar SV.

Cancer. 2013 Dec 15;119(24):4308-15. doi: 10.1002/cncr.28340. Epub 2013 Sep 19.


Renal improvement in myeloma with bortezomib plus plasma exchange.

Burnette BL, Leung N, Rajkumar SV.

N Engl J Med. 2011 Jun 16;364(24):2365-6. doi: 10.1056/NEJMc1101834. No abstract available.


Interleukin-1β-induced interleukin-6 production in A549 cells is mediated by both phosphatidylinositol 3-kinase and interleukin-1 receptor-associated kinase-4.

Eda H, Burnette BL, Shimada H, Hope HR, Monahan JB.

Cell Biol Int. 2011 Apr;35(4):355-8. doi: 10.1042/CBI20100247.


A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.

Mourey RJ, Burnette BL, Brustkern SJ, Daniels JS, Hirsch JL, Hood WF, Meyers MJ, Mnich SJ, Pierce BS, Saabye MJ, Schindler JF, South SA, Webb EG, Zhang J, Anderson DR.

J Pharmacol Exp Ther. 2010 Jun;333(3):797-807. doi: 10.1124/jpet.110.166173. Epub 2010 Mar 17.


Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.

Hope HR, Anderson GD, Burnette BL, Compton RP, Devraj RV, Hirsch JL, Keith RH, Li X, Mbalaviele G, Messing DM, Saabye MJ, Schindler JF, Selness SR, Stillwell LI, Webb EG, Zhang J, Monahan JB.

J Pharmacol Exp Ther. 2009 Dec;331(3):882-95. doi: 10.1124/jpet.109.158329. Epub 2009 Aug 31.


SD0006: a potent, selective and orally available inhibitor of p38 kinase.

Burnette BL, Selness S, Devraj R, Jungbluth G, Kurumbail R, Stillwell L, Anderson G, Mnich S, Hirsch J, Compton R, De Ciechi P, Hope H, Hepperle M, Keith RH, Naing W, Shieh H, Portanova J, Zhang Y, Zhang J, Leimgruber RM, Monahan J.

Pharmacology. 2009;84(1):42-60. doi: 10.1159/000227286. Epub 2009 Jul 4.


33-Year-old man with cough, fever, and weight loss.

Burnette BL, Beckman TJ.

Mayo Clin Proc. 2007 Oct;82(10):1265-8. No abstract available.


The expressed protein in glyphosate-tolerant soybean, 5-enolpyruvylshikimate-3-phosphate synthase from Agrobacterium sp. strain CP4, is rapidly digested in vitro and is not toxic to acutely gavaged mice.

Harrison LA, Bailey MR, Naylor MW, Ream JE, Hammond BG, Nida DL, Burnette BL, Nickson TE, Mitsky TA, Taylor ML, Fuchs RL, Padgette SR.

J Nutr. 1996 Mar;126(3):728-40.


Supplemental Content

Loading ...
Support Center